297 related articles for article (PubMed ID: 9815555)
21. Effects of tamoxifen and octreotide LAR on the IGF-system compared with tamoxifen monotherapy.
Helle SI; Mietlowski W; Guastalla JP; Szakolczai I; Bajetta E; Sommer H; Baltali E; Pinter T; Csepreghy M; Ottestad L; Boni C; Bryce C; Klijn JG; Lønning PE
Eur J Cancer; 2005 Mar; 41(5):694-701. PubMed ID: 15763644
[TBL] [Abstract][Full Text] [Related]
22. Measurement of insulin-like growth factor axis does not enhance specificity of PSA-based prostate cancer screening.
Oliver SE; Holly J; Peters TJ; Donovan J; Persad R; Gillatt D; Pearce A; Hamdy FC; Neal DE; Gunnell D
Urology; 2004 Aug; 64(2):317-22. PubMed ID: 15302487
[TBL] [Abstract][Full Text] [Related]
23. Insulin-like growth factor-I, IGF binding protein-3, and breast cancer in young women: a comparison of risk estimates using different peptide assays.
Rinaldi S; Kaaks R; Zeleniuch-Jacquotte A; Arslan AA; Shore RE; Koenig KL; Dossus L; Riboli E; Stattin P; Lukanova A; Toniolo P
Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):48-52. PubMed ID: 15668475
[TBL] [Abstract][Full Text] [Related]
24. Effect of raloxifene on insulin-like growth factor-I, insulin-like growth factor binding protein-3, and leptin in premenopausal women at high risk for developing breast cancer.
Eng-Wong J; Hursting SD; Venzon D; Perkins SN; Zujewski JA
Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1468-73. PubMed ID: 14693739
[TBL] [Abstract][Full Text] [Related]
25. Serum insulin-like growth factor is not elevated in patients with early B-cell chronic lymphocytic leukemia but is still a prognostic factor for disease progression.
Molica S; Vitelli G; Mirabelli R; Digiesu G; Giannarelli D; Cuneo A; Ribatti D; Vacca A
Eur J Haematol; 2006 Jan; 76(1):51-7. PubMed ID: 16343271
[TBL] [Abstract][Full Text] [Related]
26. Insulin-like growth factor-I, its binding proteins (IGFBP-1 and IGFBP-3), and growth hormone and breast cancer risk in The Nurses Health Study II.
Schernhammer ES; Holly JM; Hunter DJ; Pollak MN; Hankinson SE
Endocr Relat Cancer; 2006 Jun; 13(2):583-92. PubMed ID: 16728584
[TBL] [Abstract][Full Text] [Related]
27. Free dissociable insulin-like growth factor I (IGF-I), total IGF-I and their binding proteins in girls with Turner syndrome during long-term growth hormone treatment.
Bannink EM; van Doorn J; Stijnen T; Drop SL; de Muinck Keizer-Schrama SM
Clin Endocrinol (Oxf); 2006 Sep; 65(3):310-9. PubMed ID: 16918949
[TBL] [Abstract][Full Text] [Related]
28. Elevated serum insulin-like growth factor (IGF)-II and IGF binding protein-2 in patients with colorectal cancer.
Renehan AG; Jones J; Potten CS; Shalet SM; O'Dwyer ST
Br J Cancer; 2000 Nov; 83(10):1344-50. PubMed ID: 11044360
[TBL] [Abstract][Full Text] [Related]
29. Altered expression of IGFs and IGF-binding proteins during intrauterine growth restriction in guinea pigs.
Carter AM; Kingston MJ; Han KK; Mazzuca DM; Nygard K; Han VK
J Endocrinol; 2005 Jan; 184(1):179-89. PubMed ID: 15642794
[TBL] [Abstract][Full Text] [Related]
30. Serum measurements of testosterone, insulin-like growth factor 1, and insulin-like growth factor binding protein-3 in the diagnosis of prostate cancer among Korean men.
Hong SK; Han BK; Jeong JS; Jeong SJ; Moon KH; Byun SS; Lee SE
Asian J Androl; 2008 Mar; 10(2):207-13. PubMed ID: 18097534
[TBL] [Abstract][Full Text] [Related]
31. Insulin-like growth factor I (IGF-I), IGF-binding proteins, and breast cancer.
Krajcik RA; Borofsky ND; Massardo S; Orentreich N
Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1566-73. PubMed ID: 12496045
[TBL] [Abstract][Full Text] [Related]
32. Growth hormone, insulin-like growth factors and their binding proteins in adult hemodialysis patients treated with recombinant human growth hormone.
Jensen PB; Hansen TB; Frystyk J; Ladefoged SD; Pedersen FB; Christiansen JS
Clin Nephrol; 1999 Aug; 52(2):103-9. PubMed ID: 10480221
[TBL] [Abstract][Full Text] [Related]
33. Effect of raloxifene on IGF-I and IGFBP-3 in postmenopausal women with breast cancer.
Torrisi R; Baglietto L; Johansson H; Veronesi G; Bonanni B; Guerrieri-Gonzaga A; Ballardini B; Decensi A
Br J Cancer; 2001 Dec; 85(12):1838-41. PubMed ID: 11747323
[TBL] [Abstract][Full Text] [Related]
34. Influence of tamoxifen on plasma levels of insulin-like growth factor I and insulin-like growth factor binding protein I in breast cancer patients.
Lønning PE; Hall K; Aakvaag A; Lien EA
Cancer Res; 1992 Sep; 52(17):4719-23. PubMed ID: 1380889
[TBL] [Abstract][Full Text] [Related]
35. Circulating levels of insulin-like growth factors, their binding proteins, and breast cancer risk.
Schernhammer ES; Holly JM; Pollak MN; Hankinson SE
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):699-704. PubMed ID: 15767352
[TBL] [Abstract][Full Text] [Related]
36. Insulin-like growth factor binding protein-3 and insulin receptor substrate-1 in breast cancer: correlation with clinical parameters and disease-free survival.
Rocha RL; Hilsenbeck SG; Jackson JG; VanDenBerg CL; Weng Cn; Lee AV; Yee D
Clin Cancer Res; 1997 Jan; 3(1):103-9. PubMed ID: 9815544
[TBL] [Abstract][Full Text] [Related]
37. Effects of treatment with megestrol acetate, aminoglutethimide, or formestane on insulin-like growth factor (IGF) I and II, IGF-binding proteins (IGFBPs), and IGFBP-3 protease status in patients with advanced breast cancer.
Frost VJ; Helle SI; Lønning PE; van der Stappen JW; Holly JM
J Clin Endocrinol Metab; 1996 Jun; 81(6):2216-21. PubMed ID: 8964854
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of the insulin-like growth factors (IGF) IGF-I and IGF binding protein 3 in patients at high risk for breast cancer.
Trinconi AF; Filassi JR; Soares JM; Baracat EC
Fertil Steril; 2011 Jun; 95(8):2753-5. PubMed ID: 21392749
[TBL] [Abstract][Full Text] [Related]
39. Changes in systemic levels of insulin-like growth factors and their binding proteins in patients with rheumatoid arthritis.
Neidel J
Clin Exp Rheumatol; 2001; 19(1):81-4. PubMed ID: 11247331
[TBL] [Abstract][Full Text] [Related]
40. Insulin-like growth factors (IGF-I, free IGF-I and IGF-II) and insulin-like growth factor binding proteins (IGFBP-2, IGFBP-3, IGFBP-6, and ALS) in blood circulation.
Yu H; Mistry J; Nicar MJ; Khosravi MJ; Diamandis A; van Doorn J; Juul A
J Clin Lab Anal; 1999; 13(4):166-72. PubMed ID: 10414596
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]